Wealth Enhancement Advisory Services
LGND icon

Wealth Enhancement Advisory Services’s Ligand Pharmaceuticals LGND Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$298K Buy
2,604
+31
+1% +$3.55K ﹤0.01% 2632
2025
Q1 		$271K Sell
2,573
-92
-3% -$9.67K ﹤0.01% 2508
2024
Q4 		$286K Buy
+2,665
New +$286K ﹤0.01% 2400